Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corp    CVS

Delayed Quote. Delayed  - 10/24 10:01:30 pm
88 USD   +0.68%
10/21 CVS HEALTH : Pay goes live nationwide
10/20 CVS HEALTH : Safe Drug Disposal is Key to Preventing Abuse
10/20 CVS HEALTH : Announces 47 Metric Tons of Unwanted Medication Collect..
News SummaryMost relevantAll newsSector news 

CVS Caremark Corporation : U.S. asks CVS about its prescription discount plan

share with twitter share with LinkedIn share with facebook
share via e-mail
02/17/2012 | 10:28pm CEST

CVS Caremark Corp said it received requests for information about a prescription drug discount program it runs for uninsured or under-insured individuals from both the U.S. government and the Texas Attorney General.

In January, CVS received a subpoena from the U.S. Office of Inspector General requesting information about the company's Health Savings Pass program, CVS said in its 10k filing on Friday.

The company, which runs the CVS pharmacy chain and the CVS Caremark pharmacy benefits management service, said the request was connected to an investigation of possible false or otherwise improper claims for payment involving Health & Human Services programs.

In February, CVS received a civil investigative demand from Texas' Office of the Attorney General. That office requested a copy of information from the OIG subpoena and other information related to prescription drug claims submitted by CVS pharmacies to Texas Medicaid for reimbursement, the company said.

CVS said it would respond to the requests for information and cooperate with both investigations.

CVS markets its Health Savings Pass, which has a $15 annual fee, to people who do not have prescription drug coverage and to those who have limited coverage.

The Health Savings Pass lets patients fill 90-day prescriptions for 400 generic drugs for $11.99. Participants also get discounts such as 10 percent off visits at the CVS in-store health clinic, MinuteClinic and 10 percent off an annual flu shot.

The announcement comes about a month after CVS agreed to pay $5 million to settle charges of inaccurate pricing of some drugs for the elderly and disabled, ending a wide-ranging, multi-year probe into its business practices.

Shares of CVS closed down 28 cents at $44.27, after reaching a new high of $45 earlier in the day.

(Reporting by Jessica Wohl in Chicago; Editing by Richard Chang)

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CVS HEALTH CORP
10/21 CVS HEALTH : Pay goes live nationwide
10/20 CVS HEALTH : SilverScript Insurance Company, a CVS Health Company, Introduces Ne..
10/20 WOMENHEART : The National Coalition for Women with Heart Disease Receives Commun..
10/20 CVS HEALTH : Safe Drug Disposal is Key to Preventing Abuse
10/20 CVS HEALTH : Announces 47 Metric Tons of Unwanted Medication Collected Through S..
10/20 CVS HEALTH : Dorchester Wealth Management Co buys $5,458,536 stake in CVS Health..
10/20 CVS HEALTH : Pharmacy Takes Pay Nationwide Following Successful Pilot
10/20 CVS HEALTH CORP : ex-dividend day
10/19 CVS HEALTH : Pharmacy to Help Patients Understand Health Insurance Options Durin..
10/19 CVS CAREMARK : How Competition Can Increase Access and Reduce Costs
More news
Sector news : Drug Retailers - NEC
10/21DJU.S. HOT STOCKS : Hot Stocks to Watch
10/20DJWalgreens, Rite Aid Push Back Merger Deadline -- Update
10/20 Walgreens sees Rite Aid deal closing in early 2017
10/20DJWALGREENS BOOTS ALLIANCE : Rite Aid Push Back Merger Deadline
10/10DJWALGREENS BOOTS ALLIANCE : Major Investor Sues Theranos
More sector news : Drug Retailers - NEC
News from SeekingAlpha
10/20 The Drug Battle Coming To A Neighborhood Near You
10/19 The Attractiveness Of CVS At $86 Instead Of $106
10/19 CVS : Garage Sale Bargain
10/19 CVS HEALTH CORPORATION : Attractively Valued And Set Up For Double Digit Returns
10/19 Buy CVS Health - Cramer's Lightning Round (10/18/16)
Financials ($)
Sales 2016 179 801 M
EBIT 2016 10 816 M
Net income 2016 5 730 M
Debt 2016 24 813 M
Yield 2016 1,86%
P/E ratio 2016 16,87
P/E ratio 2017 14,18
EV / Sales 2016 0,66x
EV / Sales 2017 0,61x
Capitalization 93 827 M
More Financials
Duration : Period :
CVS Health Corp Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Full-screen chart
Technical analysis trends CVS HEALTH CORP
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 108 $
Spread / Average Target 22%
Consensus details
EPS Revisions
More Estimates Revisions
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Stephen J. Gold Chief Information Officer & Executive Vice Preside
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORP-9.99%93 827
More Results